New developments in weight-loss drugs: Novo Nordisk, Eli Lilly & Pfizer advance studies [lJjhB0Ychuv]

New developments in weight-loss drugs: Novo Nordisk, Eli Lilly & Pfizer advance studies [lJjhB0Ychuv]

| 1h 28m 28s | Video has closed captioning.

Dr. Angela Fitch, Knownwell chief medical officer and president of Obesity Medicine Association, joins 'Squawk Box' to discuss the advances in weight-loss drugs, what it means for the obesity epidemic in the U.S., and more. For access to live and exclusive video from CNBC subscribe to CNBC PRO: » Subscribe to CNBC TV: » Subscribe to CNBC: Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide. Connect with CNBC News Online Get the latest news: Follow CNBC on LinkedIn: Follow CNBC News on Facebook: Follow CNBC News on Twitter: Follow CNBC News on Instagram: #CNBC #CNBCTV  #ignite keto plus acv gummies #keto genix pills